New muscle relaxant drug passes early safety check in healthy volunteers
NCT ID NCT06932315
First seen Mar 06, 2026 · Last updated May 24, 2026 · Updated 9 times
Summary
This early-stage study tested a new drug called HRS-9190 in 53 healthy adults aged 18 to 45. The main goal was to check its safety and how the body processes it at different doses. Researchers measured side effects and drug levels in the blood. This study did not treat any disease but gathered important information for future research.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SKELETAL MUSCLE RELAXATION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
The Third Xiangya Hospital of Central South University
Changsha, Hunan, 410013, China
Conditions
Explore the condition pages connected to this study.